Clinical Trial: A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671391) titled 'A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants' on May 28.

Brief Summary: This study is a randomized, double-blind, placebo-controlled trial aimed at exploring the effects of LAE102 injection in combination with Tirzepatide on body composition.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Obesity Adult Onset

Intervention: DRUG: LAE102 +Tirzepatide

Receive LAE102, once a week, by subcutaneous injection.The dosage of Tirzepatide starts at lower dose, administered subcutaneously once a week, and is ...